JN Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 87: 2851-2857, 2002;
0022-3077/02 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (83)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, C.
Right arrow Articles by Bazan, N. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, C.
Right arrow Articles by Bazan, N. G.

The Journal of Neurophysiology Vol. 87 No. 6 June 2002, pp. 2851-2857
Copyright ©2002 by the American Physiological Society

Cyclooxygenase-2 Regulates Prostaglandin E2 Signaling in Hippocampal Long-Term Synaptic Plasticity

Chu Chen, Jeffery C. Magee, and Nicolas G. Bazan

Neuroscience Center, School of Medicine, Louisiana State University Health Sciences Center, New Orleans, Louisiana 70112


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Chen, Chu, Jeffery C. Magee, and Nicolas G. Bazan. Cyclooxygenase-2 Regulates Prostaglandin E2 Signaling in Hippocampal Long-Term Synaptic Plasticity. J. Neurophysiol. 87: 2851-2857, 2002. The functional significance of cyclooxygenases (COX-1 and -2), the key enzymes that convert arachidonic acid (AA) to prostaglandins (PGs) in brain, is unclear, although they have been implicated in cellular functions and in some neurologic disorders, including stroke, epilepsy, and Alzheimer's disease. Recent evidence that COX-2 is expressed in postsynaptic dendritic spines (which are specialized structures involved in synaptic signaling) and is regulated by synaptic activity implies participation of COX-2 in neuronal plasticity. However, direct evidence is lacking. Here we demonstrate that selective COX-2 inhibitors significantly reduced postsynaptic membrane excitability, back-propagating dendritic action potential-associated Ca2+ influx, and long-term potentiation (LTP) induction in hippocampal dentate granule neurons, while a COX-1 inhibitor is ineffective. All of these actions were effectively reversed by exogenous application of PGE2 but not of PGD2 or PGF2alpha . Our results indicate that COX-2-generated PGE2 regulates membrane excitability and long-term synaptic plasticity in hippocampal perforant path-dentate gyrus synapses.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Cyclooxygenase (COX) is the key enzyme that converts arachidonic acid (AA) to prostaglandins (PGs). Two isozymes of COX have been identified (Vane et al. 1998). COX-1 is constitutively expressed in most tissues and is thought to mediate "housekeeping" functions. On the other hand, COX-2, an inducible enzyme, participates in the injury/inflammatory response (Smith et al. 1996; Vane et al. 1998). Growing evidence, however, suggests that the functional significance of COX-2 is far beyond what was initially revealed (Bazan 2001; Dubois et al. 1998; Ho et al. 1999; Vane et al. 1998). In the brain, COX-2 is expressed in discrete populations of neurons and is enriched in the cortex and hippocampus (Yamagata et al. 1993) and has been implicated in brain functions and in neurologic disorders, including stroke, seizures, and Alzheimer's disease (Hewett et al. 2000; Ho et al. 1999; Iadecola et al. 2001; Miettnen et al. 1997; Nakayama et al. 1998). However, the mechanisms by which COX and PGs participate in neuronal cell signaling are still not clear.

Unlike in most tissues, "inducible" COX-2 is also constitutively expressed in brain (Yamagata et al. 1993), kidney (Dlnchuk et al. 1995; Morham et al. 1995), and a few other organs (Dubios et al. 1998; Vane et al. 1998), suggesting that its basal activity is engaged in cellular functions. Gene-deletion studies, for instance, show that mice lacking COX-2 have severe renal abnormalities and a consequently short life span (Dlnchuk et al. 1995; Morham et al. 1995; Vane et al. 1998). In the brain, basal expression of COX-2 has been shown to be regulated by synaptic activity, and its expression is upregulated by a high-frequency stimulation (HFS) that is associated with long-term potentiation (LTP) induction (Yamagata et al. 1993). Moreover, COX-2 is localized in neuronal dendritic spines where active synapses are present (Kaufmann et al. 1996). These studies imply that both constitutive and inducible COX-2 may participate in synaptic modifications. However, direct evidence is still lacking. Here we report that selective COX-2 inhibitors significantly reduced postsynaptic membrane excitability, back-propagating dendritic action potential-associated Ca2+ influx, and LTP induction in hippocampal dentate granule neurons, whereas a COX-1 inhibitor is ineffective. All of these actions were effectively reversed by exogenous application of PGE2 but not of PGD2 or PGF2alpha . Our results indicate that COX-2-generated PGE2 regulates postsynaptic membrane excitability and long-term synaptic plasticity in hippocampal perforant path-dentate gyrus synapses.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Hippocampal slice preparation

Hippocampal slices were prepared from male c-57 mice (2-3 mo; body wt, 25-34 g) using standard procedures as described previously (Chen et al. 2001). Briefly, the brain was rapidly removed after decapitation and placed in cold oxygenated (95% O2-5% CO2) low-Ca2+/high-Mg2+ slicing solution composed of (in mM) 2.5 KCl, 7.0 MgCl2, 28.0 NaHCO3, 1.25 NaH2PO4, 0.5 CaCl2, 7.0 glucose, 3 pyruvic acid, 1 ascorbic acid, and 234 sucrose. Then, slices were cut at a thickness of 400 µm and transferred to a holding chamber in an incubator containing oxygenated artificial cerebrospinal fluid (ACSF) composed of (in mM) 125.0 NaCl, 2.5 KCl, 1.0 MgCl2, 25.0 NaHCO3, 1.25 NaH2PO4, 2.0 CaCl2, 25.0 glucose, 3 pyruvic acid, and 1 ascorbic acid at 36°C. Slices were maintained in an incubator containing oxygenated ACSF at room temperature (~22-24°C) for >= 1.5 h before recordings. Slices were then transferred to a recording chamber where they were continuously perfused with the 95% O2-5% CO2-saturated standard ACSF at ~34-35°C. Individual dentate granule cells were viewed with a Zeiss Axioskop microscope, fitted with a ×60 (Olympus) water-immersion objective and differential interference contrast (DIC) optics.

Electrophysiologic recordings

Whole cell patch-clamp recordings were made using an Axoclamp-2B patch-clamp amplifier in bridge mode. Recording pipettes (6-9 MOmega ) were pulled from borosilicate glass with a micropipette puller (Sutter Instrument) and fire polished on a microforge (Narishige Scientific Instrument) prior to use. The internal pipette solution contained (in mM) 120 K gluconate, 20 KCl, 4 NaCl, 10 HEPES, 0.5 EGTA, 0.28 CaCl2, 4 Mg2ATP, 0.3 Tris2GTP, and 14 phosphocreatine (pH 7.25 with KOH). Series resistance ranged from 15 to 30 MOmega as estimated directly from the amplifier and was monitored during recordings by injection of a hyperpolarizing current (50 pA) before delivery of a stimulus. The resting membrane potential for recorded cells was around -74 mV. Excitatory postsynaptic potentials (EPSPs) were recorded in response to stimulation of the perforant path at a frequency of 0.05 Hz. Stimuli were elicited via a bipolar tungsten electrode placed in the middle of the molecular layer. The amplitude range of the evoked EPSPs was always adjusted to 2-6 mV (<30% of threshold for generating an action potential). LTP in the perforant path was induced by a HFS (consisting of 8 trains, each of 8 pulses at 200 Hz with an intertrain interval of 2 s) paired with postsynaptic depolarizing current injection (0.5 nA). LTP was operationally defined as >20% increase above baseline for the amplitude of EPSPs from 26 to 30 min after HFS. In experiments where selective COX-1 and -2 inhibitors were applied, slices were pretreated with NS398, nimesulide (Nims), or indomethacin (Indo) for >= 1.5 h and then were continuously perfused with the inhibitors during recordings. All the bath-perfused solutions, including drug solutions, contained 10 µM bicuculline to block ionotropic GABA receptors.

Ca2+ imaging

Changes in [Ca2+]i in postsynaptic neurons during somatic depolarizing current injection were imaged with the fluorescent dye fura-2 (~100 µM) in the recording pipette as described previously (Magee and Johnston 1997). The internal pipette solution for the Ca2+ imaging contained (in mM) 120 K gluconate, 20 KCl, 4 NaCl, 10 HEPES, 4 Mg2ATP, 0.3 Tris2GTP, 14 phosphocreatine, and 3 ascorbic acid (pH 7.25 with KOH). A cooled charge-coupled device (CCD) camera (Photometrics, Tucson, AZ) in a sequential frame-transfer mode was used to record high-speed fluorescence images. Relative changes in [Ca2+]i were quantified as changes in Delta F/F, where F is fluorescent intensity before stimulation (after subtraction of autofluorescence) and Delta F is the change from this value during neuron firing. The tissue autofluorescence was determined by an equivalent measurement at a parallel location in the slice that was away from the dye-filled neuron. A 380-nm light (13-nm band-pass filter; Omega Optical) was used to excite fura-2. Sequential frame rate for optical recordings was one frame every 25 ms and pixels were binned in a 5-by-5 array. Action potential-induced dendritic Ca2+ influx was imaged at cell body and at 25, 50, 100, and 125 µm or beyond from the cell body. Data were presented as means ± SE. Unless stated otherwise, Student's t-test and one-way ANOVA with Student-Newman-Keuls test were used for statistical comparison when appropriate. Differences were considered significant when P < 0.05. The care and use of the animals reported in this study were approved by the Institutional Animal Care and Use Committee of Louisiana State University Health Sciences Center.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Selective COX-2 inhibitors, but not those of COX-1, reduce LTP induction in hippocampal dentate granule neurons

To determine whether COX-2 participates in long-term synaptic plasticity in hippocampal perforant path-dentate gyrus synapses, mouse hippocampal slices were pretreated with a selective COX-2 inhibitor, NS398 (10 µM, a concentration above IC50 for COX-2 but below IC50 for COX-1) (Vane et al. 1998) for >= 1 h and continuously perfused in the recording bath. NS398 did not elicit an effect on baseline EPSPs. However, HFS paired with postsynaptic depolarizing current injection (0.5 nA)-induced enhancement of the EPSP amplitude was significantly reduced from 26 to 30 min after HFS in cells treated with NS398 (141 ± 13%, n = 16) when compared with controls (229 ± 21%, n = 18). The enhancement of the EPSP amplitude was further decreased to 121 ± 16% (n = 9) when the concentration of NS398 was raised to 30 µM (Fig. 1, C and D). To confirm that the NS398-induced inhibition of LTP induction is due to COX-2 inhibition, we employed another selective COX-2 inhibitor, nimesulide (Nims). Similar to the effects of NS398, Nims (30 µM) reduced HFS-induced potentiation of EPSP amplitude to 106 ± 18% (n = 8). We operationally defined LTP induction as >20% increase above baseline amplitude of EPSPs from 26 to 30 min after HFS. Thus it appears that selective COX-2 inhibitors significantly reduced the probability of LTP induction in hippocampal dentate granule neurons (Fig. 1B).



View larger version (45K):
[in this window]
[in a new window]
 
Fig. 1. Selective COX-2 inhibitors, but not those of COX-1, suppressed long-term potentiation (LTP) in hippocampal perforant path-dentate gyrus synapses. A: representative responses recorded from control and NS398-treated cells before (pre) and after (post) high-frequency stimulation (HFS). B: probability of LTP induction in the absence and presence of COX inhibitors, NS398, nimesulide (Nims), and indomethacin (Indo). **P < 0.01, chi  test. C: time course and extent of LTP induction following HFS (up-arrow ) in cells recorded from control, NS398-, and Indo-treated slices. Excitatory postsynaptic potential (EPSP) amplitude was normalized as percent of average baseline EPSP amplitude. Each point represents averages of 3 consecutive trials recorded at 0.05 Hz. D: mean potentiation of EPSP calculated by the average EPSP amplitude at 1-5, 16-20, and 26-30 min after HFS plotted as percent of baseline in the absence and presence of COX-1 or -2 inhibitors. The data in C and D were averaged from all the cells recorded, including those experiments in which the EPSP increases were <20%. *P < 0.05; **P < 0.01.

To further assess the significance of COX-2, we used indomethacin (Indo), a relatively effective COX-1 inhibitor (Meade et al. 1993; Yamagata et al. 1993). Application of 1 µM indo (IC50 for COX-1: 0.028 µM and for COX-2: 1.68 µM) had little effect on HFS-induced potentiation of EPSP amplitude (210 ± 16%, n = 18) and probability of LTP induction (Fig. 1).

PGE2 selectively reverses COX-2 inhibitor-induced suppression of LTP

If the effects of COX-2 inhibition on LTP induction in hippocampal dentate granule neurons result from blocking the synthesis of PGs, then exogenous application of PGs should restore the COX-2 inhibitor-induced suppression of LTP induction. To test this hypothesis, we individually applied three different PGs in the presence of NS398 (10 µM). As indicated in Fig. 2, bath application of PGE2 (0.33 µM) significantly reversed NS398 (10 µM)-induced reduction of EPSP potentiation (242 ± 29%, n = 12 vs. 141 ± 13%, n = 16) and probability of LTP induction (100%, 12 of 12 cells vs. 50%, 8 of 16 cells), whereas it had little effect on baseline EPSPs. Bath applications of PGD2 (0.33 µM) or PGF2alpha (0.33 µM) did not significantly increase HFS-induced enhancement of EPSP amplitudes and probability of LTP induction. Because COX-2 converts AA to PGE2 (Brock et al. 1999) and PGE2 receptors (EP) are expressed in the hippocampus (Narumiya et al. 1999; Zhang and Rivest 1999), it is likely that PGE2 is the main messenger in COX-2-mediated activity-dependent synaptic plasticity.



View larger version (46K):
[in this window]
[in a new window]
 
Fig. 2. PGE2 or increasing postsynaptic membrane depolarization reversed NS398-induced reduction of LTP. A: bath application of PGE2 recovered NS398-induced inhibition of LTP. B: mean potentiation of EPSP calculated as indicated in Fig. 1 in the presence of NS398 alone and NS398 plus PGD2, PGE2, and PGF2alpha , respectively. **P < 0.01 different from NS398 alone; #P < 0.05 different from PGE2 + NS398. C: increase in postsynaptic depolarizing current injection (0.8 nA) during HFS relieved NS398-induced reduction of LTP. D: mean potentiation of EPSP in cells given 0.8-nA current injection. *P < 0.05, **P < 0.01.

Action of PGE2 on synaptic modification is not on presynaptic sites

It has been proposed that the bioactive lipids AA and platelet-activating factor (PAF) are retrograde messengers that modulate hippocampal long-term synaptic plasticity (Bazan 1995; Kato et al. 1994; O'Dell et al. 1991; Williams et al. 1989). To determine whether the role of COX-2 in regulating PG signaling in hippocampal synaptic plasticity is similar to that of other bioactive lipids, we examined the effects of postsynaptic application of PGE2 on spontaneous miniature EPSPs (mEPSPs). As shown in Fig. 3, when included in the recording pipette solution, 2 µM PGE2 did not induce significant effects on frequency or amplitude of mEPSPs during 20-min recordings (Kato et al. 1994). We also used paired-pulse protocol (inter-pulse interval, 80-100 ms) to examine the presynaptic effect of COX-2 inhibition (Chen et al. 2001; Zucker 1989). We did not detect differences in the ratios of the paired-pulse facilitation in the absence or presence of COX-2 inhibitors (control: 1.04 ± 0.03, n = 11; 10 µM NS398: 1.01 ± 0.02, n = 16). This indicates that the action of COX-2 reaction products on synaptic modification does not involve presynaptic terminals but postsynaptic sites.



View larger version (27K):
[in this window]
[in a new window]
 
Fig. 3. Postsynaptic application of PGE2 did not change the amplitude and frequency of miniature EPSPs (mEPSPs). A and B: representative traces of mEPSPs in the absence and presence of PGE2 (2 µM). PGE2 was postsynaptically applied via the recording pipette. Bicuculline (10 µM) and TTX (0.5 µM) were added to the bath solution. C: mean frequency of mEPSPs in the absence and presence of PGE2. D: mean median amplitudes of mEPSPs in the absence and presence of PGE2. Data were analyzed using the Mini-analysis program.

COX-2 inhibition reduces postsynaptic membrane excitability

It has been demonstrated that PGE2 regulates membrane excitability by modulating K+, Ih, and TTX-resistant Na+ channel currents in sensory neurons (Gold et al. 1998; Ingram and Williams 1996; Nicol et al. 1997). Recent evidence reveals the importance of spatiotemporal correlation of coincidence of postsynaptic firing and EPSPs in synaptic efficacy (Bi and Poo 2001; Koester and Sakmann 1998; Magee and Johnston 1997; Markram et al. 1997). Thus reducing postsynaptic membrane excitability, which causes a decrease in the number of the postsynaptic action potentials (APs) during presynaptic HFS, decreases the probability of LTP induction. To determine whether the inhibition of COX-2 activity altered postsynaptic membrane excitability, we examined the number of APs elicited by presynaptic HFS paired with postsynaptic current injection. As illustrated in Fig. 4, NS398 (10 and 30 µM) and Nims (30 µM) significantly reduced the number of APs, whereas Indo had little effect on the membrane excitability. Bath application of PGD2 or PGF2alpha (0.33 µM) did not recover NS398 (10 µM)-induced reduction in the number of APs. Correlated to LTP induction, PGE2 (0.33 µM) significantly reversed NS398 (10 µM)-induced decrease in the number of APs (Fig. 4). These data suggest that basal activity of COX-2 plays an important role in regulating membrane excitability and that COX-2 inhibitor-mediated inhibition of LTP induction may result from reduced postsynaptic membrane excitability. The reduction of postsynaptic membrane excitability caused a decrease in the synchrony of the coincidence of EPSPs and postsynaptic APs that regulates synaptic efficacy (Bi and Poo 2001; Koester and Sakmann 1998; Markram et al. 1997). To evaluate this hypothesis, we reduced the amount of postsynaptic current injection from 0.5 to 0.3 nA during presynaptic HFS. Reduction of postsynaptic depolarizing current injection caused a reduction in the number of APs and consequent LTP induction. Further, we increased postsynaptic depolarizing current injection from 0.5 to 0.8 nA in cells treated with NS398 (10 µM). An increase in the current injection induced an increase in the number of APs and LTP induction (Figs. 2, C and D, and 4, A and B). Therefore a correlation existed between the number of postsynaptic spikes during the tetanus and the magnitude of EPSP potentiation (Fig. 4F). To further examine effects of COX-2-generated PGE2 on postsynaptic membrane properties, we measured membrane input resistance and the amount of current required to trigger an AP (current threshold). NS398 (10 µM) reduced the membrane input resistance and increased the current threshold. PGE2 (0.33 µM) significantly reversed NS398-induced decrease in input resistance and increase in current threshold (Fig. 4G). This finding suggests that PGE2 derived from the tonic activity of constitutive COX-2 contributes to the membrane excitability.



View larger version (44K):
[in this window]
[in a new window]
 
Fig. 4. COX-2 inhibitors reduced the number of spikes and PGE2 restored NS398-induced suppression of firing initiated during the tetanus. A-D: representative action potential waveforms in the absence (A) and presence of NS398 (B), Indo (C), and NS398 + PGE2 (D). These bursts shown in A-D were from a single train stimulation. E: mean values of number of action potentials (APs) during the tetanus under different conditions. *P < 0.05, different from the control; #P < 0.05, different from NS398. F: scatter plot of the EPSP amplitude from 26 to 30 min after HFS vs. number of APs in neurons recorded from different conditions. The averaged number of spikes shown in E and F were from the entire LTP-inducing stimuli, which include 8 trains. G: PGE2 restored NS398-induced reduction of input resistance (measured from current injections ranging from -50 to +50 pA) and increase of current threshold. **P < 0.01, different from the control; ##P < 0.01, different from NS398 alone.

COX-2 inhibition reduces back-propagating dendritic action potential-associated Ca2+ influx

Active propagation of axonally initiated APs back into the dendrites and associated dendritic Ca2+ influx play a critical role in hippocampal LTP induction (Magee and Johnston 1997). To test whether the COX-2 inhibitor-induced decrease in postsynaptic membrane excitability resulted in an inhibition of back-propagating dendritic APs, dendritic [Ca2+]i changes were imaged during somatic depolarizing current injection. As indicated in Fig. 5, NS398 (10 µM) significantly decreased dendritic Ca2+ influx at 100 µm (normalized Delta F/F: 0.54 ± 0.03, n = 8) and >125 µm (0.34 ± 0.08, n = 4) from soma when compared with the control (0.79 ± 0.02, n = 9 and 0.64 ± 0.06, n = 8, respectively). Bath application of PGE2 (0.33 µM) restored dendritic Ca2+ influx to control level (0.75 ± 0.04, n = 11 and 0.56 ± 0.05, n = 9 at 100 and >125 µm, respectively). These optical Ca2+-imaging data indicate that NS398 significantly decreased back-propagating dendritic AP amplitudes and associated Ca2+ influx and that PGE2 was able to rescue the COX-2 inhibitor-induced inhibition.



View larger version (99K):
[in this window]
[in a new window]
 
Fig. 5. COX-2 inhibitor decreased action potential-induced dendritic Ca2+ influx. A: optical recordings of [Ca2+]i in hippocampal dentate granule neurons. The neuron was filled with the calcium indicator fura-2 (~100 µM) via a somatic whole cell recording pipette and allowed to dialyze for >10 min. B: relative fluorescence changes Delta F/F elicited by action potentials. Traces in different colors show Delta F/F imaged from the boxes indicated in A. C: somatic recordings of 8 action potentials evoked by current injection (750 pA, 40 ms). D: action potential-induced changes with the distance from soma. Delta F/F was normalized to the maximum signal. E: averages of normalized Delta F/F recorded from 100 and >125 µm under different conditions. **P < 0.01, different from the control; #P < 0.05, different from NS398 + PGE2; ##P < 0.01, different from NS398 + PGE2.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Our findings provide the first direct evidence that COX-2, but not COX-1, regulates PG signaling in hippocampal long-term synaptic plasticity. Our data also reveal that COX-2-generated PGE2 is an important signaling molecule in modifying synaptic efficacy because it effectively reversed selective COX-2 inhibitor-induced decreases in the number of APs during HFS, back-propagating dendritic AP-associated Ca2+ influx, and LTP induction. It is likely that COX-2 participates in hippocampal synaptic plasticity through regulation of PGE2 signaling in modulating postsynaptic membrane excitability. Thus the inhibition of COX-2 activity induces the reduction of PGE2 level that causes a decrease in postsynaptic membrane excitability. This, in turn, reduces the number of APs or back-propagating dendritic AP amplitude and associated Ca2+ influx through voltage-gated Ca2+ channels and N-methyl-D-aspartate receptors (NMDA), which is critical for the induction of LTP.

It appears that COX-2 generated PGE2 does not serve as a retrograde messenger to act on presynaptic sites as AA and PAF do (Bazan 1995; Kato et al. 1994; O'Dell et al. 1991; Williams et al. 1989) because the inhibition of COX-2 with selective COX-2 inhibitors or exogenous application PGE2 did not elicit changes in the amplitude and frequency of mEPSPs or the ratios of paired-pulse facilitation before and after HFS. However, these manipulations did induce the change in the number of postsynaptic membrane APs during HFS, indicating that COX-2 reaction products may act on the postsynaptic sites.

In the present study, we observed that the number of APs during HFS paired with postsynaptic current injection was reduced in slices pretreated with the COX-2 inhibitor. Because this is a rapid response and the action occurs within a few milliseconds, it is unlikely that this reduction was due to the blockade of new synthesis of enzyme derived from the inducible COX-2. We know that prostanoids are not classic neurotransmitters. They are not stored in or secreted from synaptic vesicles. Once synthesized, they diffuse rapidly to and activate their specific membrane receptors. This means that PGE2 signaling in this rapid response must be dependent on basal COX-2 expression rather than on the inducible COX-2 expression (Yamagata et al. 1993). This postulation has been supported by evidence that both COX-2 mRNA and protein in unstimulated brain are expressed at relatively high levels in a number of neurons involved in cognitive functions, including hippocampal granule, pyramidal cells, and cortical neurons. In particular, COX-2 protein is expressed at a very high level in dentate granule cells under basal conditions (Yamagata et al. 1993). In addition, COX-2 is consistently localized in dendritic spines of neurons that receive synaptic input (Kaufmann et al. 1996). Our results, that the membrane input resistance and current threshold had altered before HFS in slices pretreated with the COX-2 inhibitor, also provide evidence that basal activity of COX-2-generated PGE2 may dynamically regulate membrane excitability. Because COX-2 expression is upregulated rapidly by HFS that is associated with LTP induction (Yamagata et al. 1993), it is possible that constitutive COX-2 may contribute to the induction of LTP as we observed in the present study and that inducible COX-2 may contribute to the maintenance of LTP.

One possibility for the COX-2 inhibitor-induced reduction of LTP may be due to its acting on postsynaptic NMDA receptor channels because the perforant path-dentate LTP is dependent on the NMDA receptors. We have tested this possibility and found that the number of APs elicited during LTP-inducing stimulation trains in the presence of the NMDA receptor antagonist 2-amino-5-phosphonovaleric acid (APV, 50 µM) and NS398 (10 µM) was similar to that of NS398 alone (data not shown). In addition, we also tested the possibility that the COX-2 inhibitors affected adrenergic receptors because the perforant path-dentate LTP has been shown to, in part, depend on beta -adrenergic receptors (Stanton and Sarvey 1985). Application of the beta -adrenergic receptor antagonist, propranolol (1 µM) did not induce a change in the number of spikes during LTP-inducing stimulation trains in the absence and presence of NS398 (data not shown). Thus it is unlikely that the COX-2 inhibitor-induced changes in membrane excitability and long-term plasticity result from their directly acting on the NMDA or beta -adrenergic receptors. Recent progress in synaptic physiology reveals that the back-propagating dendritic APs are a critical element in the induction of long-term synaptic plasticity in hippocampal pyramidal neurons (Magee and Johnston 1997). Postsynaptic APs are initiated in the axon and then propagate back into the dendritic arbor of neurons, evoking an activity-dependent dendritic Ca2+ influx. An elevation of the postsynaptic intracellular free [Ca2+] contributes to long-lasting changes in the efficacy of glutamatergic synapses. In hippocampal CA1 pyramidal neurons, transient A-type K+ channels and hyperpolarization-activated cation channels increase their density with the distance from soma to distal dendrites (Hoffman et al. 1997; Magee 1998), and they shape EPSPs and modulate the back-propagating dendritic APs via protein kinases A and C (PKA and PKC) (Hoffman and Johnston 1998). AA, the precursor of PGs, has been shown to alter the availability of transient and sustained dendritic K+ channels that may underlie AA-induced increase in the amplitude of back-propagating dendritic APs (Colbert and Pan 1999). In sensory neurons, PGE2 regulates membrane excitability through the cAMP-mediated modulation of ionic conductances, including K+, Ih, and TTX-resistant Na+ channel currents (Gold et al. 1998; Ingram and Williams 1996; Nicol et al. 1997). Thus it is likely that selective COX-2 inhibitor-induced decrease in the postsynaptic membrane excitability may result from a relief of PGE2 modulation of these channels; consequently, reduced postsynaptic membrane excitability would cause decreases in the number and amplitude of back-propagating dendritic APs, resulting in the reduction of the probability of LTP induction in hippocampal dentate granule neurons. Although we did not examine the effects of the COX-2 inhibition or PGE2 on K+, Ih, or Na+ channel activities in the present study, it would be interesting to investigate the COX-2 reaction-product modulation of these channels in hippocampal neurons.

Our data reveal that basal activity of constitutively inducible COX-2 plays an important role in regulating membrane excitability and activity-dependent LTP induction in the hippocampus. These findings will further our understanding of physiologic and pathologic events mediated by COX and the significance of PGs in memory storage and neurologic diseases.


    ACKNOWLEDGMENTS

We thank Dr. Elena B. Rodriguez de Turco for helpful comments on the manuscript and V. Marcheselli for technical help.

This work was supported by National Institute of Neurological Disorders and Stroke Grant R01NS-23002 and National Science Foundation Grant NSF/Louisiana Education Quality Support Fund (LEQSF) (2001-04)-RII-01 [Experimental Program to Stimulate Competitive Research (EPSCoR)].


    FOOTNOTES

Address for reprint requests: C. Chen, Neuroscience Center, Louisiana State University Health Sciences Center, 2020 Gravier St., Suite D, New Orleans, LA 70112 (E-mail: cchen{at}lsuhsc.edu).

Received 9 October 2001; accepted in final form 7 February 2002.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

0022-3077/02 $5.00 Copyright © 2002 The American Physiological Society



This article has been cited by other articles:


Home page
J PsychopharmacolHome page
T. Ishida, T. Sato, M. Irifune, K.-i. Tanaka, N. Nakamura, and T. Nishikawa
Effect of acetaminophen, a cyclooxygenase inhibitor, on Morris water maze task performance in mice
J Psychopharmacol, September 1, 2007; 21(7): 757 - 767.
[Abstract] [PDF]


Home page
Learn. Mem.Home page
D. Albrecht
Angiotensin-(1-7)-induced plasticity changes in the lateral amygdala are mediated by COX-2 and NO
Learn. Mem., March 8, 2007; 14(3): 177 - 184.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
Y. Akaneya and T. Tsumoto
Bidirectional Trafficking of Prostaglandin E2 Receptors Involved in Long-Term Potentiation in Visual Cortex
J. Neurosci., October 4, 2006; 26(40): 10209 - 10221.
[Abstract] [Full Text] [PDF]


Home page
NeuroscientistHome page
N. Sang and C. Chen
Lipid Signaling and Synaptic Plasticity
Neuroscientist, October 1, 2006; 12(5): 425 - 434.
[Abstract] [PDF]


Home page
J. Physiol.Home page
N. Sang, J. Zhang, and C. Chen
PGE2 glycerol ester, a COX-2 oxidative metabolite of 2-arachidonoyl glycerol, modulates inhibitory synaptic transmission in mouse hippocampal neurons
J. Physiol., May 1, 2006; 572(3): 735 - 745.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
N. Sang, J. Zhang, V. Marcheselli, N. G. Bazan, and C. Chen
Postsynaptically Synthesized Prostaglandin E2 (PGE2) Modulates Hippocampal Synaptic Transmission via a Presynaptic PGE2 EP2 Receptor
J. Neurosci., October 26, 2005; 25(43): 9858 - 9870.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. De Gois, M. K.-H. Schafer, N. Defamie, C. Chen, A. Ricci, E. Weihe, H. Varoqui, and J. D. Erickson
Homeostatic Scaling of Vesicular Glutamate and GABA Transporter Expression in Rat Neocortical Circuits
J. Neurosci., August 3, 2005; 25(31): 7121 - 7133.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini
Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors
Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
L. K. Bekar, M. E. Loewen, K. Cao, X. Sun, J. Leis, R. Wang, G. W. Forsyth, and W. Walz
Complex Expression and Localization of Inactivating Kv Channels in Cultured Hippocampal Astrocytes
J Neurophysiol, March 1, 2005; 93(3): 1699 - 1709.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
C. Chen and N. G. Bazan
Endogenous PGE2 Regulates Membrane Excitability and Synaptic Transmission in Hippocampal CA1 Pyramidal Neurons
J Neurophysiol, February 1, 2005; 93(2): 929 - 941.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
C. Iadecola and P. B. Gorelick
The Janus Face of Cyclooxygenase-2 in Ischemic Stroke: Shifting Toward Downstream Targets
Stroke, February 1, 2005; 36(2): 182 - 185.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Vazquez-Tello, L. Fan, X. Hou, J.-S. Joyal, J. A. Mancini, C. Quiniou, R. I. Clyman, F. Gobeil Jr., D. R. Varma, and S. Chemtob
Intracellular-specific colocalization of prostaglandin E2 synthases and cyclooxygenases in the brain
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1155 - R1163.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
L. McCullough, L. Wu, N. Haughey, X. Liang, T. Hand, Q. Wang, R. M. Breyer, and K. Andreasson
Neuroprotective Function of the PGE2 EP2 Receptor in Cerebral Ischemia
J. Neurosci., January 7, 2004; 24(1): 257 - 268.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
N. G. Bazan
Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor
J. Lipid Res., December 1, 2003; 44(12): 2221 - 2233.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
S. S. Newton, E. F. Collier, J. Hunsberger, D. Adams, R. Terwilliger, E. Selvanayagam, and R. S. Duman
Gene Profile of Electroconvulsive Seizures: Induction of Neurotrophic and Angiogenic Factors
J. Neurosci., November 26, 2003; 23(34): 10841 - 10851.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. Sanchez-Moreno, M. P. Cano, B. de Ancos, L. Plaza, B. Olmedilla, F. Granado, and A. Martin
High-Pressurized Orange Juice Consumption Affects Plasma Vitamin C, Antioxidative Status and Inflammatory Markers in Healthy Humans
J. Nutr., July 1, 2003; 133(7): 2204 - 2209.
[Abstract] [Full Text] [PDF]


Home page
Sci Aging Knowl EnvironHome page
P. L. McGeer and E. G. McGeer
Innate Immunity, Local Inflammation, and Degenerative Disease
Sci. Aging Knowl. Environ., July 24, 2002; 2002(29): re3 - 3.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (83) <